Treatment News : HIV Itself Is a Major Heart Disease Risk Factor - by David Evans

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » February 2009

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


February 11, 2009

HIV Itself Is a Major Heart Disease Risk Factor

by David Evans

HIV infection itself appears to increase the thickness of the carotid artery and is therefore a significant independent risk factor for developing cardiovascular disease (CVD)—ultimately increasing the risk of a heart attack or stroke—according to a new study presented Wednesday, February 11, at the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montreal.

Ever since researchers first noticed that protease inhibitors could significantly increase a person’s cholesterol and triglycerides, they have attempted to quantify the additional risk that people with HIV may have in developing CVD. Subsequent research over the years has suggested that some protease inhibitors and the nucleoside reverse transcriptase inhibitor abacavir (found in Ziagen, Epzicom and Trizivir) may increase a person’s CVD risk somewhat. Research also appeared to show that people with HIV were more likely than their HIV-negative peers to have heart attacks. Thus far, however, no study has adequately quantified the additional risk that the virus itself may confer.

To explore this, Carl Grunfeld, MD, from the University of California in San Francisco, and his colleagues compared the carotid artery thickness of 433 HIV-positive patients to 5,749 HIV-negative patients. The thickness of the carotid artery in the neck—called carotid intima-media thickness—can be measured using ultrasound; when found to be thicker than normal, it tends to predict the likelihood of cardiovascular events such as heart attacks.

Specifically, Grunfeld and his colleagues looked at the thickness of the artery in two spots. Previous research, focusing a segment of the artery known as the common carotid, had failed to consistently show thickening in people with HIV. Grunfeld and his team reasoned that increased thickness of the internal carotid, which is higher up and closer to the brain, would be a better indicator of inflammation that may be caused by HIV infection, due to the turbulent nature of the blood flow there.

Sure enough, Grunfeld’s team found a significant increase in thickness in the internal carotid artery in people with HIV. In fact, HIV infection alone was associated with the same amount, if not more, of thickening in the internal carotid artery that is associated with other factors such as age, smoking and diabetes. The impact was even more pronounced in HIV-positive women.

Grunfeld showed that the increases in thickness of the internal carotid artery were not as significant in the common carotid, where most previous studies had looked. He said this could explain why some previous studies had failed to find associations between HIV and artery thickening.

Grunfeld conceded in his talk that although the study’s sample size was large, he could not yet directly link increases in artery thickness to clinical events such as heart attacks. He did, however, indicate that studies in the general population consistently demonstrate that people with thicker carotid arteries have a much higher risk of CVD.

When asked what the underlying mechanism may be, he indicated it is likely a complex combination of each person’s immune system response to HIV along with the negative influence of some HIV treatments.

Search: HIV, risk, cardiovascular disease, CVD, heart attack, stroke, carotid, ultrasound, Grunfeld

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.